In this video, Dr Aaron Miller explains the application of the new McDonald criteria and discusses sources of misdiagnosis for multiple sclerosis.
Diagnosis and misdiagnosis of multiple sclerosis
Dr. Miller has disclosed that he is/was a grant/research support recipient for Novartis, Genzyme/Sanofi, Mallinckrodt, Roche/Genentech, MedDay, that he was/is a consultant/advisor for Biogen Idec, Celgene, Accordant Health Services (Caremark), Corrona, EMD Serono, Genzyme/Sanofi, Mallinckrodt, Mapi-Pharma, Novartis, Roche/Genentech and that he is/was on the speaker’s bureau for Biogen Idec (unbranded disease awareness programs only), EMD Serono (unbranded journal club)